Only the variant chr22:g.29695793:A>C, proximal to CHEK2, showed a numerical trend toward HRD enrichment.
← all excerpts
Tumor Mutational Burden in Cervical Cancer as Potential Marker for Immunotherapy Responders.
1
—
—
Only the variant chr22:g.29695793:A>C, proximal to CHEK2, showed a numerical trend toward HRD enrichment.